|
Jul 30
|
Here's Why Fresenius (FMS) Looks Ripe for Bottom Fishing
|
|
Jul 29
|
UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs
|
|
Jul 29
|
Universal Health Q2 Earnings Beat on Strong Acute Care Admissions
|
|
Jul 29
|
Here's Why Fresenius (FMS) is a Strong Value Stock
|
|
Jul 29
|
Is the Options Market Predicting a Spike in Fresenius Medical Stock?
|
|
Jul 24
|
Community Health Q2 Earnings Miss on Declining Patient Days
|
|
Jul 24
|
Molina Healthcare Q2 Earnings Miss on Rising Medical Care Costs
|
|
Jul 21
|
FMS or SONVY: Which Is the Better Value Stock Right Now?
|
|
Jun 30
|
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
|
|
Jun 25
|
Tajila Mullahkhel Featured in In-Depth Interview Exploring Her Journey from Afghanistan to Engineering Innovator
|
|
Jun 25
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jun 17
|
Health Care Roundup: Market Talk
|
|
Jun 17
|
Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs
|
|
Jun 17
|
Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation
|
|
Mar 3
|
Fresenius Medical Care (ETR:FME) Will Pay A Larger Dividend Than Last Year At €1.44
|
|
Feb 25
|
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025
|